HAL (France)open access
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
Chronic kidney disease, Type 2 diabetes, Cardiovascular complications, 0, Finerenone
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 137631
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.